Abstract
Sintilimab is a fully human IgG4 monoclonal antibody against programmed death-1 (PD-1) used to treat classical Hodgkin's lymphoma and various solid tu......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
